Cargando…

Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates

BACKGROUND: Kidney transplantation is the most effective treatment for end-stage kidney disease. Sensitization, the formation of human leukocyte antigen (HLA) antibodies, remains a major barrier to successful kidney transplantation. Despite the implementation of desensitization strategies, many cand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yabu, Julie M., Siebert, Janet C., Maecker, Holden T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831845/ https://www.ncbi.nlm.nih.gov/pubmed/27078882 http://dx.doi.org/10.1371/journal.pone.0153355

Ejemplares similares

B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy
por: Beausang, John F., et al.
Publicado: (2017)

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
por: Toyoda, Mieko, et al.
Publicado: (2017)

HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates
por: Rushakoff, Joshua A., et al.
Publicado: (2022)

A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
por: Ide, Kentaro, et al.
Publicado: (2015)

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients
por: Noble, Johan, et al.
Publicado: (2021)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
por: Choi, Ashley Y., et al.
Publicado: (2021)

Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial
por: Wilson, Nancy, et al.
Publicado: (2023)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

HLA Desensitization Based on Results of the Luminex Technique in Kidney Transplant – A Single-center Experience
por: Bansal, S.B., et al.
Publicado: (2021)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience
por: Kauke, Teresa, et al.
Publicado: (2016)

From Hesitancy to Certainty: A Case of Successful Desensitization in High Risk HLA Incompatible Kidney Transplantation
por: Pandey, Prashant, et al.
Publicado: (2021)

A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation
por: Zhao, Daqiang, et al.
Publicado: (2023)

Editorial: Sensitization and Desensitization in Organ Transplantation
por: Anwar, Imran J., et al.
Publicado: (2021)

Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient
por: Inui, Masashi, et al.
Publicado: (2016)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

Immune profiling of COVID-19: preliminary findings and implications for the pandemic
por: Maecker, Holden T
Publicado: (2021)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
por: Manook, Miriam, et al.
Publicado: (2023)

Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates
por: Rostaing, Lionel, et al.
Publicado: (2016)

Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023)

Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children
por: Adamusiak, Anna M., et al.
Publicado: (2016)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
por: Schönermarck, Ulf, et al.
Publicado: (2011)

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
por: Joher, Nizar, et al.
Publicado: (2021)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study
por: Bureau, Côme, et al.
Publicado: (2023)

NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates
por: DeWolfe, David, et al.
Publicado: (2019)

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging
por: Whiting, Chan C., et al.
Publicado: (2015)

Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature
por: Thukral, Sharmila, et al.
Publicado: (2019)

Increasing access to kidney transplantation for sensitized recipient through three-way kidney paired donation with desensitization: The first Indian report
por: Kute, Vivek B, et al.
Publicado: (2016)

Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights
por: Sorohan, Bogdan Marian, et al.
Publicado: (2022)

Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model
por: Bath, Natalie M., et al.
Publicado: (2019)

Excellent outcome after desensitization in high immunologic risk kidney transplantation
por: Lim, Jeong-Hoon, et al.
Publicado: (2019)

Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients
por: Kjellman, Christian, et al.
Publicado: (2021)

Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report
por: Song, Seung Hwan, et al.
Publicado: (2016)

Baseline immune profile by CyTOF can predict response to an investigational adjuvanted vaccine in elderly adults
por: Lingblom, Christine M. D., et al.
Publicado: (2018)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization
por: Osickova, Klara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lu53240nje50sgunld4bs6h4hm